# Screening Study for Participants With Malignant Tumors

> **NCT05419375** · PHASE2 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 470 (actual)

## Conditions studied

- Solid Tumors

## Interventions

- **OTHER:** Screening platform

## Key facts

- **NCT ID:** NCT05419375
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-22
- **Primary completion:** 2025-09-03
- **Final completion:** 2025-09-03
- **Target enrollment:** 470 (ACTUAL)
- **Last updated:** 2026-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05419375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05419375, "Screening Study for Participants With Malignant Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05419375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*